Skip to main content

Beta Bionics, Inc.

For the period ended Dec 31, 2024. Filed Mar 25, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 25, 2025

BBNX$16.95+8.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 2. Properties

Substantially all of our operations are currently conducted at leased facilities, including our manufacturing processes, research and development activities, customer and technical support, and management and administrative functions. As of December 31, 2024, we leased facilities with an aggregate total of approximately 73,969 square feet, as follows:

11 Hughes, Irvine, CA 92618: 50,020 square feet of manufacturing, general administrative, and research and development office space, which also serves as our corporate headquarters. The lease term will expire in June 2032 and we have one option to extend the term of the lease for an additional period of five years.

12671 High Bluff Drive, Suites 100, 130, and 330 San Diego, CA 92130: 10,064 square feet of general administrative and customer and technical support office space. The lease term for Suite 100 will expire in February 2027, and we have one option to the extend the term of the lease for a period of five years. The lease and sublease terms for Suites 130 and 330 will expire in March 2027 and July 2025, respectively.

300 Baker Ave, Suite 301, Concord, MA 01742: 13,035 square feet of general administrative and research and development office space. The lease term will expire in October 2026 and we have one option to extend the term of the lease for an additional period of five years.

194 S Hanover Street, Suite 102, Pottstown, PA 19464: 850 square feet of general administrative office space. The lease term is month-to-month.

We believe that our existing facilities are adequate to meet our current needs, and that suitable additional alternative spaces will be available in the future on commercially reasonable terms if deemed necessary.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.